Adult kidney stem cells found in fish

Research may be a first step toward better care

January 26, 2011

By B. D. Colen, Harvard Staff Writer

Courtesy of Alan Davidson

A new study “provides a proof of principle that adult kidney stem cells exist in nature and that treating renal disease with a stem cell-type therapy is theoretically possible,” said Alan J. Davidson, a professor at Harvard Medical School when the work was conducted.

It has long been a given that adult humans — and mammals in general — lack the capacity to grow new nephrons, the kidney’s delicate blood filtering tubules, which has meant that dialysis, and ultimately kidney transplantation, is the only option for the more than 450,000 Americans who have kidney failure.

The study, published online this week (Jan. 26) in the journal Nature, “provides a proof of principle that adult kidney stem cells exist in nature and that treating renal disease with a stem cell-type therapy is theoretically possible,” said Davidson, interviewed by phone in his native New Zealand, where he is now an associate professor in molecular medicine and pathology at the University of Auckland.

Zebrafish are a commonly used animal model for studying organ development and various diseases because of the ease with which they can be genetically manipulated and because they are transparent in their larval stages. Researchers can literally look inside live fish and watch as their organs develop and function. In this case, working with specially developed zebrafish from the University of Pittsburgh that had fluorescent renal stem cells, the research team, which included Robert I. Handin, a Harvard Medical School professor of medicine and co-director of the Hematology Division at Brigham and Women’s Hospital, was able to watch the cells grow into new nephrons in real time.

“Investigators have been searching for the adult renal stem cell in mice and humans for some time, but so far the results have been controversial,” said Davidson. There is a general belief that while there are kidney stem cells in mammals, including humans, they generate nephrons and then disappear during fetal development or soon after birth. “The mystery,” said Davidson, “is why these particular cells aren’t retained in the adult kidney, where they could be called upon to make new nephrons.”

The researchers found that when the kidney stem cells were transplanted, they began generating new nephrons, and those nephrons could then successfully be transplanted into other zebrafish, demonstrating the continuing ability of the stem cells to generate nephrons.

While it’s a long way from the zebrafish kidney to a human treatment for kidney disease, Davidson notes, “There are many organs and tissues that have a genetic program that is shared between fish and mammals. Our work has demonstrated the therapeutic potential of adult renal stem cells; the next step is to apply this knowledge to mammals in order to isolate or induce the equivalent cell type.” The prospect of a cell-based therapy to regenerate aged or diseased kidneys has an obvious clinical appeal and may lead to better treatment for the millions of people worldwide struggling with chronic kidney disease.

A new study “provides a proof of principle that adult kidney stem cells exist in nature and that treating renal disease with a stem cell-type therapy is theoretically possible,” said Alan J. Davidson, a professor at Harvard Medical School when the work was conducted.

Targeting mechanisms in the central nervous system might yield the beneficial effects of low-calorie diets on healthy aging without the need to alter food intake, suggests new research from Harvard T.H. Chan School of Public Health.

Jose Gomez-Ibanez, a transportation and infrastructure policy expert at Harvard Kennedy School and the Harvard Graduate School of Design, talks about the political and financial hurdles to smoothly running public transit systems.

Harvard researchers at Massachusetts General Hospital find that participating in an eight-week mindfulness meditation program appears to make measurable changes in brain regions associated with memory, sense of self, empathy, and stress.

Related

A group of Harvard Stem Cell Institute researchers has made such a significant leap forward in reprogramming human adult cells that HSCI co-director Douglas Melton said the institute will immediately begin using the new method to make patient- and disease-specific induced pluripotent stem cells, known as iPS cells.

An interdisciplinary group of leading Harvard geneticists and stem cell researchers has found a new genetic aspect of cell reprogramming that may ultimately help in the fine-tuning of induced pluripotent stem cells (iPS) into specific cell types.

A team of Harvard Stem Cell Institute researchers at Massachusetts General Hospital and collaborators at Harvard’s School of Engineering and Applied Sciences has taken a giant step toward possibly using human stem cells to repair damaged hearts.

When the baby vomited again, Gail Melton knew something was seriously wrong with her second child, a son she and her husband, Doug Melton, had named Sam.
She phoned Doug and took Sam to Harvard Health Services in Holyoke Center. Doug hurried to the clinic from his Fairchild Biochemistry Building lab on Divinity Avenue. Together Gail and Doug rushed their infant son to Children’s Hospital Boston.